Dr. Nair brings more than 30 years of experience in biopharma, life sciences and biomedical research. He currently serves on the board of the Institute for Protein Innovation, CellBio Scientific, and BioIVT, a Linden portfolio company. Most recently, he was a partner at Digitalis Ventures leading their efforts in company creation and platform building in the life sciences space. Prior to that, he was the Executive Vice President of The Jackson Laboratory (JAX) and President of JAX® Mice, Clinical and Research Services business. Before that, he was Vice President of Marketing & Sales at Caliper Life Sciences. Earlier in his career, Dr. Nair held various scientific and operational management roles at GlaxoSmithKline’s FDA-approved site in Singapore.